Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38082

ARPC1A Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

ARPC1A Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal cell population with disrupted ARPC1A gene, encoding a critical subunit of the Arp2/3 complex. This model enables investigation of actin nucleation defects that impair lamellipodia-driven migration and endocytosis, with relevance to cancer metastasis and immune dysfunction. Utilizing HEK293T host cells, the polyclonal format allows rapid screening of ARPC1A loss on actin dynamics and signaling pathways regulated by Rac1 and WASP/N-WASP, making it suitable for live-cell imaging, invasion assays, and co-immunoprecipitation studies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ARPC1A

    Gene Identifier

    NCBI Gene ID 10552

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ARPC1A Knockout HEK293T Polyclonal Cells product consists of a CRISPR/Cas9-edited polyclonal knockout cell population generated by disrupting the endogenous ARPC1A locus in HEK293T cells. This population contains a heterogeneous mix of loss-of-function alleles, offering a versatile system for rapid interrogation of ARPC1A function. Designed for researchers studying actin cytoskeleton dynamics, the product eliminates the time-intensive step of single-cell cloning while enabling pooled assays that reveal the collective impact of gene disruption on cellular phenotypes.

HEK293T cells are a widely used human embryonic kidney cell line engineered to stably express the SV40 large T antigen, which promotes episomal replication of plasmids containing the SV40 origin and thereby amplifies transient protein expression. Derived from adenovirus 5 DNA-transformed HEK293 cells, they exhibit high transfection efficiency and robust growth, making them a standard host for recombinant protein production, lentiviral packaging, and cytoskeletal investigations. The well-characterized actin cytoskeleton of HEK293T cells provides an ideal platform for examining how ARPC1A knockout influences lamellipodial dynamics and endocytic trafficking.

ARPC1A encodes the p41 subunit of the actin-related protein 2/3 (Arp2/3) complex, a heptameric nucleator of branched actin filaments. Together with ARPC2?C5, ARP2, and ARP3, it forms a stable complex that binds pre-existing filaments and nucleates new ones at a 70?? angle upon activation by NPFs such as WASP, N-WASP, and the WAVE complex. These NPFs function downstream of Rac1 and Cdc42 GTPases, transducing signals from integrins and growth factor receptors. Cortactin stabilizes the resulting branches. Disruption of ARPC1A abrogates F-actin polymerization, lamellipodia formation, endocytic scission, and cell spreading.

In HEK293T cells, ARPC1A loss disrupts actin-based processes essential for normal morphology and motility. These cells rely on Arp2/3-mediated branching to generate lamellipodia and support efficient clathrin-mediated endocytosis. Knockout populations are predicted to show diminished membrane protrusion, slower wound closure, and reduced uptake of endocytic cargo. The model is particularly valuable for dissecting how SV40 T antigen expression may intersect with Arp2/3-dependent nuclear actin functions or viral particulate trafficking, offering a unique context for mechanistic studies.

The ARPC1A Knockout HEK293T Polyclonal Cells support a broad range of assays, including live-cell actin imaging, transwell invasion, and co-immunoprecipitation of the Arp2/3 complex with NPFs like N-WASP and cortactin. Phalloidin-based F-actin staining and western blotting provide direct readouts of cytoskeletal reorganization and target protein loss. Applications span cancer metastasis studies, immune synapse characterization, and investigation of actin-related neurodevelopmental disorders. For technical assistance, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)